CHRISTINA RATLIFF: Open Payments
NPI 1558802959 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,143 in 99 payments from 28 companies in 2025. Trend: 2023 $1,451 · 2024 $1,583 · 2025 $2,143
Food & beverage: $2,143
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $310 |
| Janssen Biotech, Inc. | 10 | $211 |
| Daiichi Sankyo Inc. | 11 | $195 |
| E.R. Squibb & Sons, L.L.C. | 9 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $142 |
| Celgene Corporation | 5 | $128 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Gilead Sciences, Inc. | 5 | $114 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| PFIZER INC. | 4 | $81 |
Products named: Enhertu, OPDIVO, REBLOZYL, Trodelvy, RYBREVANT, ERLEADA, KISQALI, ICLUSIG.
Industry payments across FL — which companies pay providers there.
